Fortrea 将收购 Worldwide Clinical Trials 的临床药理部门和生物分析实验室业务

Fortrea has signed a definitive agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million in cash. The acquisition includes a GLP bioanalytical lab in Austin, a 200-bed clinical pharmacology unit in San Antonio, and a biosampling facility in Pflugerville, Texas. This strategic move strengthens Fortrea's end-to-end clinical development platform and early-stage capabilities, while allowing Worldwide to focus on its faster-growing late-stage business in oncology, neuroscience, internal medicine, and rare diseases.